Next Article in Journal
Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
Next Article in Special Issue
Six New Tetraprenylated Alkaloids from the South China Sea Gorgonian Echinogorgia pseudossapo
Previous Article in Journal / Special Issue
First Report of a Peroxiredoxin Homologue in Jellyfish: Molecular Cloning, Expression and Functional Characterization of CcPrx4 from Cyanea capillata

Holothurian Fucosylated Chondroitin Sulfate

Program of Glycobiology, Institute of Medical Biochemistry Leopoldo de Meis, and University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-913, Brazil
Mar. Drugs 2014, 12(1), 232-254;
Received: 5 November 2013 / Revised: 23 December 2013 / Accepted: 30 December 2013 / Published: 9 January 2014
(This article belongs to the Collection Bioactive Compounds from Marine Invertebrates)
Fucosylated chondroitin sulfate (FucCS) is a structurally distinct glycosaminoglycan found in sea cucumber species. It has the same backbone composition of alternating 4-linked glucuronic acid and 3-linked N-acetyl galactosamine residues within disaccharide repeating units as regularly found in mammalian chondroitin sulfates. However, FucCS has also sulfated fucosyl branching units 3-O-linked to the acid residues. The sulfation patterns of these branches vary accordingly with holothurian species and account for different biological actions and responses. FucCSs may exhibit anticoagulant, antithrombotic, anti-inflammatory, anticancer, antiviral, and pro-angiogenic activities, besides its beneficial effects in hemodialysis, cellular growth modulation, fibrosis and hyperglycemia. Through an historical overview, this document covers most of the science regarding the holothurian FucCS. Both structural and medical properties of this unique GAG, investigated during the last 25 years, are systematically discussed herein. View Full-Text
Keywords: carbohydrate-based drug development; chondroitin sulfate; fucose; sulfated glycosaminoglycan; echinoderm; therapeutic actions carbohydrate-based drug development; chondroitin sulfate; fucose; sulfated glycosaminoglycan; echinoderm; therapeutic actions
Show Figures

Graphical abstract

MDPI and ACS Style

Pomin, V.H. Holothurian Fucosylated Chondroitin Sulfate. Mar. Drugs 2014, 12, 232-254.

AMA Style

Pomin VH. Holothurian Fucosylated Chondroitin Sulfate. Marine Drugs. 2014; 12(1):232-254.

Chicago/Turabian Style

Pomin, Vitor H. 2014. "Holothurian Fucosylated Chondroitin Sulfate" Marine Drugs 12, no. 1: 232-254.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop